Quality Systems and Risk Management Approaches for Networked Drug Development David A. Moyer VP, Regulatory Compliance Programs Fulcrum Pharma Developments,
Pharmaceutical Product Quality Assurance Through CMC Drug Development Process Presented by Darlene Rosario (Aradigm) 21 October 2003 Meeting of the Advisory.
Company Introduction. THE FRONTAGE ADVANTAGE Attention, Efficiency, and Expertise.
You, Us and Dataseam Making a Difference in Kentucky A Big Difference December 8, 2009 Dr. James R. Ramsey President University of Louisville.
2 “The label is the most important product that a company’s research arm produces…” Essence of Licensure Conveys the Use of the Product Describes Efficacy.
You, Us and Dataseam Making a Difference in Kentucky A Big Difference
